Han Witjes

1.0k total citations
35 papers, 653 citations indexed

About

Han Witjes is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Han Witjes has authored 35 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 16 papers in Reproductive Medicine and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Han Witjes's work include Ovarian function and disorders (14 papers), Reproductive Biology and Fertility (10 papers) and Assisted Reproductive Technology and Twin Pregnancy (10 papers). Han Witjes is often cited by papers focused on Ovarian function and disorders (14 papers), Reproductive Biology and Fertility (10 papers) and Assisted Reproductive Technology and Twin Pregnancy (10 papers). Han Witjes collaborates with scholars based in United States, Netherlands and United Kingdom. Han Witjes's co-authors include Bernadette Mannaerts, Keith Gordon, Georg Griesinger, Efstratios M. Κolibianakis, K. Gordon, A. Nyboe Andersen, Rik de Greef, Claus Yding Andersen, Paul Devroey and Karthick Vishwanathan and has published in prestigious journals such as Analytical Chemistry, Cancer Research and Diabetes.

In The Last Decade

Han Witjes

34 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Witjes United States	14	402	400	184	120	105	35	653
Stefanos Zervoudis Greece	11	104 0.3×	74 0.2×	49 0.3×	60 0.5×	134 1.3×	55	665
F.J. Rodríguez‐Escudero Spain	11	195 0.5×	165 0.4×	126 0.7×	39 0.3×	103 1.0×	47	478
Peter Fox Australia	9	75 0.2×	98 0.2×	40 0.2×	91 0.8×	46 0.4×	26	468
Vibeke Schiøler Denmark	12	112 0.3×	88 0.2×	52 0.3×	40 0.3×	123 1.2×	20	431
Chun Gao China	11	59 0.1×	73 0.2×	38 0.2×	76 0.6×	78 0.7×	26	437
Fufan Zhu China	13	49 0.1×	103 0.3×	155 0.8×	30 0.3×	209 2.0×	22	578
Keyan Wang China	12	146 0.4×	174 0.4×	103 0.6×	40 0.3×	183 1.7×	51	544
J. Brian Szender United States	12	138 0.3×	95 0.2×	29 0.2×	33 0.3×	86 0.8×	34	538
Irene Mutz‐Dehbalaie Austria	9	175 0.4×	32 0.1×	88 0.5×	31 0.3×	80 0.8×	14	440

Countries citing papers authored by Han Witjes

Since Specialization

Citations

This map shows the geographic impact of Han Witjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Witjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Witjes more than expected).

Fields of papers citing papers by Han Witjes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Witjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Witjes. The network helps show where Han Witjes may publish in the future.

Co-authorship network of co-authors of Han Witjes

This figure shows the co-authorship network connecting the top 25 collaborators of Han Witjes. A scholar is included among the top collaborators of Han Witjes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Witjes. Han Witjes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Witjes, Han, et al.. (2025). Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema. Clinical and Translational Science. 18(11). e70388–e70388.

Witjes, Han, et al.. (2024). DONIDALORSEN EXPOSURE-RESPONSE ANALYSIS: HEREDITARY ANGIOEDEMA ATTACK RATE VERSUS PLASMA PREKALLIKREIN CONCENTRATION RELATIONSHIP. Annals of Allergy Asthma & Immunology. 133(6). S25–S25. 1 indexed citations

Connarn, Jamie N., Han Witjes, Rik de Greef, et al.. (2023). Characterizing the exposure–response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma. CPT Pharmacometrics & Systems Pharmacology. 12(11). 1687–1697. 6 indexed citations

Brookfield, Kathleen, Hadiza Galadanci, Lihong Du, et al.. (2021). Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia. AJOG Global Reports. 1(4). 100018–100018. 3 indexed citations

Ahamadi, Malidi, Paul M. Diderichsen, Rik de Greef, et al.. (2019). Operating characteristics of stepwise covariate selection in pharmacometric modeling. Journal of Pharmacokinetics and Pharmacodynamics. 46(3). 273–285. 16 indexed citations

Witjes, Han, Mitchell D. Creinin, Inger Sundström Poromaa, Allison Martin Nguyen, & Tjeerd Korver. (2015). Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea. The European Journal of Contraception & Reproductive Health Care. 20(4). 296–307. 30 indexed citations

Mardešić, T, Bernadette Mannaerts, Mostafa I. Abuzeid, et al.. (2014). Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective analysis of the Engage trial. Reproductive BioMedicine Online. 28(4). 462–468. 8 indexed citations

Broekmans, F. J., Paul E. Verweij, Marinus J.C. Eijkemans, Bernadette Mannaerts, & Han Witjes. (2014). Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol. Human Reproduction. 29(8). 1688–1697. 42 indexed citations

Frattarelli, John L., Torbjörn Hillensjø, Frank J. Broekmans, et al.. (2013). Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation. Reproductive Biology and Endocrinology. 11(1). 90–90. 7 indexed citations

10.

Griesinger, Georg, Bernadette Mannaerts, Claus Yding Andersen, et al.. (2013). Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertility and Sterility. 100(6). 1622–1628.e3. 109 indexed citations

11.

Qiao, Jie, Guangxiu Lu, Hua Chen, et al.. (2012). A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates. Gynecological Endocrinology. 28(10). 800–804. 18 indexed citations

12.

Boostanfar, R., Bernadette Mannaerts, Samuel C. Pang, et al.. (2012). A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone. Fertility and Sterility. 97(6). 1351–1358. 20 indexed citations

13.

Boostanfar, R., et al.. (2012). A large double-blind efficacy and safety trial of corifollitropin alfa versus daily recombinant FSH in women 35 to 42 years of age undergoing ovarian stimulation prior to IVF or ICSI (pursue trial). Fertility and Sterility. 98(3). S34–S34. 5 indexed citations

14.

Doody, Kevin J., Paul Devroey, Arthur Leader, Han Witjes, & Bernadette Mannaerts. (2011). No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. Reproductive BioMedicine Online. 23(4). 449–456. 20 indexed citations

15.

Griesinger, Georg, Daniel B. Shapiro, Efstratios M. Κolibianakis, Han Witjes, & Bernadette Mannaerts. (2011). No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH. Reproductive BioMedicine Online. 23(4). 457–465. 31 indexed citations

16.

Andersen, A. Nyboe, et al.. (2011). Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Human Reproduction. 26(12). 3413–3423. 95 indexed citations

17.

Boostanfar, R., Bernadette Mannaerts, Han Witjes, & Paul Devroey. (2011). international differences in IVF live birth rates and cumulative ongoing pregnancy rates following ovarian stimulation with corifollitropin alfa or recombinant FSH. Fertility and Sterility. 96(3). S174–S174. 1 indexed citations

18.

Fatemi, Human M., Janine Oberyé, Biljana Popovic-Todorovic, et al.. (2010). Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. Fertility and Sterility. 94(5). 1922–1924. 20 indexed citations

19.

Doody, Kevin J., Paul Devroey, Keith Gordon, Han Witjes, & Bernadette Mannaerts. (2009). LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles. Reproductive BioMedicine Online. 20(4). 565–567. 19 indexed citations

20.

Witjes, Han, Arjan W. Simonetti, & L.M.C. Buydens. (2001). Peer Reviewed: Better Brain Imaging with Chemometrics. Analytical Chemistry. 73(19). 548 A–556 A. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact